1.Gluckman, PD, Cutfield, W, Hofman, P, Hanson, MA. The fetal, neonatal, and infant environments-the long-term consequences for disease risk. Early Hum Dev. 2005; 81, 51–59.
2.Simmons, RA. Developmental origins of adult disease. Pediatr Clin North Am. 2009; 56, 449–466.
3.Yajnik, CS, Deshmukh, US. Maternal nutrition, intrauterine programming and consequential risks in the offspring. Rev Endocr Metab Disord. 2008; 9, 203–211.
4.Barker, D. Fetal origins of coronary heart disease. BMJ. 1995; 311, 171–174.
5.Barker, DJ. Intrauterine programming of adult disease. Mol Med Today. 1995; 1, 418–423.
6.Barker, DJ. Fetal nutrition and cardiovascular disease in later life. Br Med Bull. 1997; 53, 96–108.
7.Barker, DJ, Eriksson, JG, Forsen, T, Osmond, C. Fetal origins of adult disease: strength of effects and biological basis. Int J Epidemiol. 2002; 31, 1235–1239.
8.Barker, DJ, Osmond, C. Infant mortality, childhood nutrition, and ischaemic heart disease in England and Wales. Lancet. 1986; 1, 1077–1081.
9.Barker, DJ, Osmond, C, Golding, J, Kuh, D, Wadsworth, ME. Growth in utero, blood pressure in childhood and adult life, and mortality from cardiovascular disease. BMJ. 1989; 298, 564–567.
10.Barker, DJ, Osmond, C, Law, CM. The intrauterine and early postnatal origins of cardiovascular disease and chronic bronchitis. J Epidemiol Community Health. 1989; 43, 237–240.
11.Barker, DJ. The foetal and infant origins of inequalities in health in Britain. J Public Health Med. 1991; 13, 64–68.
12.Wadhwa, PD, Buss, C, Entringer, S, Swanson, JM. Developmental origins of health and disease: brief history of the approach and current focus on epigenetic mechanisms. Semin Reprod Med. 2009; 27, 358–368.
13.Barker, DJP. Fetal nutrition and cardiovascular disease in later life. Br Med Bull. 1997; 53, 96–108.
14.Dyer, JS, Rosenfeld, CR. Metabolic imprinting by prenatal, perinatal, and postnatal overnutrition: a review. Semin Reprod Med. 2011; 29, 266–276.
15.Sinclair, KD, Lea, RG, Rees, WD, Young, LE. The developmental origins of health and disease: current theories and epigenetic mechanisms. Soc Reprod Fertil Suppl. 2007; 64, 425–443.
16.Fowden, AL, Giussani, DA, Forhead, AJ. Intrauterine programming of physiological systems: causes and consequences. Physiology. 2006; 21, 29–37.
17.Rinaudo, P, Wang, E. Fetal programming and metabolic syndrome. Ann Rev Physiol. 2012; 74, 107–130.
18.Rueda-Clausen, CF, Morton, JS, Davidge, ST. The early origins of cardiovascular health and disease: who, when, and how. Semin Reprod Med. 2011; 29, 197–210.
19.Ojeda, NB, Grigore, D, Alexander, BT. Role of fetal programming in the development of hypertension. Future Cardiol. 2008; 4, 163–174.
20.Woods, LL. Maternal nutrition and predisposition to later kidney disease. Curr Drug Targets. 2007; 8, 906–913.
21.Beydoun, H, Saftlas, AF. Physical and mental health outcomes of prenatal maternal stress in human and animal studies: a review of recent evidence. Paediatr Perinat Epidemiol. 2008; 22, 438–466.
22.Ward, AM, Phillips, DI. Fetal programming of stress responses. Stress. 2001; 4, 263–271.
23.Salihu, HM, Mbah, AK, Alio, AP, Kirby, RS. AGA-primed uteri compared with SGA-primed uteri and the success of subsequent in utero fetal programming. Obstet Gynecol. 2008; 111, 935–943.
24.Johnson, EM, Newman, LM, Schmidt, RR. Postnatal effects of prenatal insult. Risk Anal. 1988; 8, 35–44.
25.Gabory, A, Attig, L, Junien, C. Epigenetic mechanisms involved in developmental nutritional programming. World J Diabetes. 2011; 2, 164–175.
26.Fowden, AL, Forhead, AJ. Endocrine mechanisms of intrauterine programming. Reproduction. 2004; 127, 515–526.
27.Velez, DR, Fortunato, S, Thorsen, P, et al. Spontaneous preterm birth in African Americans is associated with infection and inflammatory response gene variants. Am J Obstet Gynecol. 2009; 200, 209e201–209e227.
28.Uchide, N, Ohyama, K, Bessho, T, Toyoda, H. Induction of pro-inflammatory cytokine gene expression and apoptosis in human chorion cells of fetal membranes by influenza virus infection: possible implications for maintenance and interruption of pregnancy during infection. Med Sci Monit. 2005; 11, RA7–RA16.
29.Romero, R, Chaiworapongsa, T, Espinoza, J. Micronutrients and intrauterine infection, preterm birth and the fetal inflammatory response syndrome. J Nutr. 2003; 133(Suppl 2), 1668S–1673S.
30.Young, LE. Imprinting of genes and the Barker hypothesis. Twin Res. 2001; 4, 307–317.
31.Bird, A. Perceptions of epigenetics. Nature. 2007; 447, 396–398.
32.Callinan, PA, Feinberg, AP. The emerging science of epigenomics. Hum Mol Genet. 2006; 15(Spec No 1), R95–R101.
33.Burdge, GC, Hanson, MA, Slater-Jefferies, JL, Lillycrop, KA. Epigenetic regulation of transcription: a mechanism for inducing variations in phenotype (fetal programming) by differences in nutrition during early life? Br J Nutr. 2007; 97, 1036–1046.
34.Crider, KS, Yang, TP, Berry, RJ, Bailey, LB. Folate and DNA methylation: a review of molecular mechanisms and the evidence for folate's role. Adv Nutr. 2012; 3, 21–38.
35.Jacob, RA. Folate, DNA methylation, and gene expression: factors of nature and nurture. Am J Clin Nutr. 2000; 72, 903–904.
36.Lewis, RM, Cleal, JK, Hanson, MA. Review: placenta, evolution and lifelong health. Placenta. 2012; 33(Suppl), S28–S32.
37.Myatt, L. Placental adaptive responses and fetal programming. J Physiol. 2006; 572(Pt 1), 25–30.
38.Baig, U, Belsare, P, Watve, M, Jog, M. Can thrifty gene(s) or predictive fetal programming for thriftiness lead to obesity? J Obes. 2011; 2011, 861049.
39.Wells, JC. Environmental quality, developmental plasticity and the thrifty phenotype: a review of evolutionary models. Evol Bioinform Online. 2007; 3, 109–120.
40.Wells, JC. The thrifty phenotype as an adaptive maternal effect. Biol Rev Camb Philos Soc. 2007; 82, 143–172.
41.Wells, JC. The thrifty phenotype: an adaptation in growth or metabolism? Am J Hum Biol. 2011; 23, 65–75.
42.Fisher, RE, Steele, M, Karrow, NA. Fetal programming of the neuroendocrine-immune system and metabolic disease. J Pregnancy. 2012; 2012, 792934.
43.Geisel, J. Folic acid and neural tube defects in pregnancy: a review. J Perinat Neonatal Nurs. 2003; 17, 268–279.
44.Wilson, RD, Johnson, JA, Wyatt, P, et al. Pre-conceptional vitamin/folic acid supplementation 2007: the use of folic acid in combination with a multivitamin supplement for the prevention of neural tube defects and other congenital anomalies. JOGC. 2007; 29, 1003–1026.
45.Dominguez-Salas, P, Cox, SE, Prentice, AM, Hennig, BJ, Moore, SE. Maternal nutritional status, C(1) metabolism and offspring DNA methylation: a review of current evidence in human subjects. Proc Nutr Soc. 2012; 71, 154–165.
46.Yajnik, CS, Deshmukh, US. Fetal programming: maternal nutrition and role of one-carbon metabolism. Rev Endocr Metab Disord. 2012; 13, 121–127.
47.Hussain, N. Epigenetic influences that modulate infant growth, development, and disease. Antioxid Redox Signal. 2012; 17, 224–236.
48.Green, BN, Johnson, CD, Adams, A. Writing narrative literature reviews for peer-reviewed journals: secrets of the trade. J Chiropr Med. 2006; 5, 101–117.
49.Wilcox, AJ. On the importance and the unimportance of birthweight. Int J Epidemiol. 2001; 30, 1233–1241.
50.Goh, YI, Koren, G. Folic acid in pregnancy and fetal outcomes. J Obstet Gynaecol. 2008; 28, 3–13.
51.Kalhan, SC, Marczewski, SE. Methionine, homocysteine, one carbon metabolism and fetal growth. Rev Endocr Metab Disord. 2012; 13, 109–119.
52.Yajnik, CS, Deshmukh, US. Maternal nutrition, intrauterine programming and consequential risks in the offspring. Rev Endocr Metab Disord. 2008; 9, 203–211.
53.Sinclair, KD, Allegrucci, C, Singh, R, et al. DNA methylation, insulin resistance, and blood pressure in offspring determined by maternal periconceptional B vitamin and methionine status. Proc Natl Acad Sci USA. 2007; 104, 19351–19356.
54.Smits, LJ, Essed, GG. Short interpregnancy intervals and unfavourable pregnancy outcome: role of folate depletion. Lancet. 2001; 358, 2074–2077.
55.Solanky, N, Requena Jimenez, A, D'Souza, SW, Sibley, CP, Glazier, JD. Expression of folate transporters in human placenta and implications for homocysteine metabolism. Placenta. 2010; 31, 134–143.
56.Rosenquist, TH, Finnell, RH. Genes, folate and homocysteine in embryonic development. Proc Nutr Soc. 2001; 60, 53–61.
57.Scholl, TO, Johnson, WG. Folic acid: influence on the outcome of pregnancy. Am J Clin Nutr. 2000; 71(Suppl 5), 1295S–1303S.
58.Kramer, MS, Kahn, SR, Rozen, R, et al. Vasculopathic and thrombophilic risk factors for spontaneous preterm birth. Int J Epidemiol. 2009; 38, 715–723.
59.Murphy, MM, Fernandez-Ballart, JD. Homocysteine in pregnancy. Adv Clin Chem. 2011; 53, 105–137.
60.Burdge, GC, Lillycrop, KA. Nutrition, epigenetics, and developmental plasticity: implications for understanding human disease. Ann Rev Nutr. 2010, 315–339.
61.Dean, W, Lucifero, D, Santos, F. DNA methylation in mammalian development and disease. Birth Defects Res C Embryo Today. 2005; 75, 98–111.
62.Yin, LJ, Zhang, Y, Lv, PP, et al. Insufficient maintenance DNA methylation is associated with abnormal embryonic development. BMC Med. 2012; 10, 26.
63.Jansson, T, Powell, TL. Role of the placenta in fetal programming: underlying mechanisms and potential interventional approaches. Clin Sci (Lond). 2007; 113, 1–13.
64.Simhan, HN, Himes, KP, Venkataramanan, R, Bodnar, LM. Maternal serum folate species in early pregnancy and lower genital tract inflammatory milieu. Am J Obstet Gynecol. 2011; 205, 61.e1–61.e7.
65.Courtemanche, C, Elson-Schwab, I, Mashiyama, ST, Kerry, N, Ames, BN. Folate deficiency inhibits the proliferation of primary human CD8+ T lymphocytes in vitro. J Immunol. 2004; 173, 3186–3192.
66.Dhur, A, Galan, P, Hercberg, S. Folate status and the immune system. Prog Food Nutr Sci. 1991; 15, 43–60.
67.Hill, AB. The environment and disease: association or causation? Proc R Soc Med. 1965; 58, 295–300.
68.American College of Cardiology Foundation and American Heart Association. Methodology Manual and Policies From the ACCF/AHA Task Force on Practice Guidelines, 2011. Washington, D.C.: American College of Cardiology Foundation and American Heart Association Inc.
69.Rumbold, A, Middleton, P, Pan, N, Crowther, CA. Vitamin supplementation for preventing miscarriage. Cochrane Database of Systematic Reviews. 2011. doi: Cd004073. 10.1002/14651858.CD004073.pub3(1).
70.Mahomed, K. Folate supplementation in pregnancy (Withdrawn Paper. 2005, art no. CD00183). Cochrane Database of Systematic Reviews. 2007; July 18(3).
71.Imdad, A, Yakoob, MY, Bhutta, ZA. The effect of folic acid, protein energy and multiple micronutrient supplements in pregnancy on stillbirths. BMC Public Health. 2011; 11(Suppl 3), S4.
72.Ramakrishnan, U, Manjrekar, R, Rivera, J, Gonzales-Cossio, T, Martorell, R. Micronutrients and pregnancy outcome: a review of the literature. Nutr Res. 1999; 19, 103–159.
73.Charles, DHM, Ness, AR, Campbell, D, et al. Folic acid supplements in pregnancy and birth outcome: re-analysis of a large randomised controlled trial and update of Cochrane review. Paediatr Perinat Epidemiol. 2005; 19, 112–124.
74.Mathews, F, Yudkin, P, Neil, A. Influence of maternal nutrition on outcome of pregnancy: prospective cohort study. BMJ. 1999; 319, 339–343.
75.Nilsen, RM, Vollset, SE, Monsen, ALB, et al. Infant birth size is not associated with maternal intake and status of folate during the second trimester in Norwegian pregnant women. J Nutr. 2010; 140, 572–579.
76.Stefanidis, K, Stefos, T, Vekris, A, et al. Folate status during labor: relationship with pregnancy outcomes. J Matern Fetal Med. 1999; 8, 61–63.
77.Timmermans, S, Jaddoe, VWV, Hofman, A, Steegers-Theunissen, RPM, Steegers, EAP. Periconception folic acid supplementation, fetal growth and the risks of low birth weight and preterm birth: the Generation R Study. Br J Nutr. 2009; 102, 777–785.
78.Goldenberg, RL, Tamura, T, Cliver, SP, et al. Serum folate and fetal growth retardation: a matter of compliance? Obstet Gynecol. 1992; 79(Pt 1), 719–722.
79.Tamura, T, Goldenberg, RL, Freeberg, LE, et al. Maternal serum folate and zinc concentrations and their relationships to pregnancy outcome. Am J Clin Nutr. 1992; 56, 365–370.
80.Van Dijk, AE, Van Eijsden, M, Stronks, K, Gemke, R, Vrijkotte, TGM. Maternal depressive symptoms, serum folate status, and pregnancy outcome: results of the Amsterdam born children and their development study. Am J Obstet Gynecol. 2010; 203, 563.e1–563.e7.
81.Takimoto, H, Hayashi, F, Kusama, K, et al. Elevated maternal serum folate in the third trimester and reduced fetal growth: a longitudinal study. J Nutr Sci Vitaminol. 2011; 57, 130–137.
82.Sram, RJ, Binkova, B, Lnenickova, Z, Solansky, I, Dejmek, J. The impact of plasma folate levels of mothers and newborns on intrauterine growth retardation and birth weight. Mutat Res. 2005; 591, 302–310.
83.Gomes, TS, Lindner, U, Tennekoon, KH, et al. Homocysteine in small-for-gestational age and appropriate-for-gestational age preterm neonates from mothers receiving folic acid supplementation. Clin Chem Lab Med. 2010; 48, 1157–1161.
84.Shaw, GM, Carmichael, SL, Yang, W, Siega-Riz, AM, Study, NBDP. Periconceptional intake of folic acid and food folate and risks of preterm delivery. Am J Perinatol. 2011, 28, 747–752.
85.Siega-Riz, AM, Savitz, DA, Zeisel, SH, Thorp, JM, Herring, A. Second trimester folate status and preterm birth. Am J Obstet Gynecol. 2004; 191, 1851–1857.
86.Bukowski, R, Malone, FD, Porter, FT, et al. Preconceptional folate supplementation and the risk of spontaneous preterm birth: a cohort study. PLoS Med. 2009; 6, e1000061.
87.Pastor-Valero, M, Navarrete-Munoz, EM, Rebagliato, M, et al. Periconceptional folic acid supplementation and anthropometric measures at birth in a cohort of pregnant women in Valencia, Spain. Br J Nutr. 2011; 105, 1352–1360.
88.van Eijsden, M, Smits, LJM, van der Wal, MF, Bonsel, GJ. Association between short interpregnancy intervals and term birth weight: the role of folate depletion. Am J Clin Nutr. 2008; 88, 147–153.
89.Gindler, J, Li, Z, Berry, RJ, et al. Folic acid supplements during pregnancy and risk of miscarriage. Lancet. 2001; 358, 796–800.
90.Bhutta, ZA, Lassi, ZS, Blanc, A, Donnay, F. Linkages among reproductive health, maternal health, and perinatal outcomes. Semin Perinatol. 2010; 34, 434–445.
91.St-Laurent, J, De Wals, P, Moutquin, JM, et al. Biopsychosocial determinants of pregnancy length and fetal growth. Pediatr Perinat Epidemiol. 2008; 22, 240–248.
92.Engel, GL. The need for a new medical model: a challenge for biomedicine. Science. 1977; 196, 129–136.
93.Stineman, MG, Streim, JE. The biopsycho-ecological paradigm: a foundational theory for medicine. PM R. 2010; 2, 1035–1045.
94.Baraka, MA, Steurbaut, S, Leemans, L, et al. Determinants of folic acid use in a multi-ethnic population of pregnant women: a cross-sectional study. J Perinat Med. 2011; 39, 685–692.
95.Canfield, MA, Przybyla, SM, Case, AP, et al. Folic acid awareness and supplementation among Texas women of childbearing age. Prev Med. 2006; 43, 27–30.
96.Goldberg, BB, Alvarado, S, Chavez, C, et al. Prevalence of periconceptional folic acid use and perceived barriers to the postgestation continuance of supplemental folic acid: survey results from a Teratogen Information Service. Birth Defects Res A. 2006; 76, 193–199.
97.de Jong-van den Berg, LTW, Hernandez-Diaz, S, Werler, MM, Louik, C, Mitchell, AA. Trends and predictors of folic acid awareness and periconceptional use in pregnant women. Am J Obstet Gynecol. 2005; 192, 121–128.
98.Forster, DA, Wills, G, Denning, A, Bolger, M. The use of folic acid and other vitamins before and during pregnancy in a group of women in Melbourne, Australia. Midwifery. 2009; 25, 134–146.
99.McGuire, M, Cleary, B, Sahm, L, Murphy, DJ. Prevalence and predictors of periconceptional folic acid uptake-prospective cohort study in an Irish urban obstetric population. Hum Reprod. 2010; 25, 535–543.
100.Imhoff-Kunsch, B, Flores, R, Dary, O, Martorell, R. Wheat flour fortification is unlikely to benefit the neediest in Guatemala. J Nutr. 2007; 137, 1017–1022.
101.Oakley, GP Jr, Tulchinsky, TH. Folic acid and vitamin B12 fortification of flour: a global basic food security requirement. Public Health Rev. 2010; 32, 284–295.
102.van Eijsden, M, van der Wal, MF, Bonsel, GJ. Folic acid knowledge and use in a multi-ethnic pregnancy cohort: the role of language proficiency. Bjog-Int J Obstet Gy. 2006; 113, 1446–1451.
103.Ray, JG, Singh, G, Burrows, RF. Evidence for suboptimal use of periconceptional folic acid supplements globally. Bjog-Int J Obstet Gy. 2004; 111, 399–408.
104.Nilsen, RM, Vollset, SE, Gjessing, HK, et al. Patterns and predictors of folic acid supplement use among pregnant women: the Norwegian mother and child cohort study. Am J Clin Nutr. 2006; 84, 1134–1141.
105.Paulik, E, Csaszar, J, Kozinszky, Z, Nagymajtenyi, L. Preconceptional and prenatal predictors of folic acid intake in Hungarian pregnant women. Eur J Obstet Gynecol Reprod Biol. 2009; 145, 49–52.
106.Yang, QH, Carter, HK, Mulinare, J, et al. Race-ethnicity differences in folic acid intake in women of childbearing age in the United States after folic acid fortification: findings from the National Health and Nutrition Examination Survey, 2001–2002. Am J Clin Nutr. 2007; 85, 1409–1416.
107.Burguet, A, Kaminski, M, Abraham-Lerat, L, et al. The complex relationship between smoking in pregnancy and very preterm delivery. Results of the epipage study. Bjog-Int J Obstet Gy. 2004; 111, 258–265.
108.Jauniaux, E, Burton, GJ. Morphological and biological effects of maternal exposure to tobacco smoke on the feto-placental unit. Early Hum Dev. 2007; 83, 699–706.
109.Salihu, HM, Aliyu, MH, Pierre-Louis, BJ, Alexander, GR. Levels of excess infant deaths attributable to maternal smoking during pregnancy in the United States. Matern Child Health J. 2003; 7, 219–227.
110.Mannino, DM, Mulinare, J, Ford, ES, Schwartz, J. Tobacco smoke exposure and decreased serum and red blood cell folate levels: data from the Third National Health and Nutrition Examination Survey. Nicotine Tob Res. 2003; 5, 357–362.
111.Ashford, KB, Hahn, E, Hall, L, et al. The effects of prenatal secondhand smoke exposure on preterm birth and neonatal outcomes. J Obstet Gynecol Neonatal Nurs. 2010; 39, 525–535.
112.Alio, AP, Salihu, HM, Kornosky, JL, Richman, AM, Marty, PJ. Feto-infant health and survival: does paternal involvement matter? Matern Child Health J. 2010; 14, 931–937.
113.Suarez, L, Felkner, M, Brender, J, Canfield, M, Hendricks, K. Maternal exposures to cigarette smoke, alcohol, and street drugs and neural tube defect occurrence in offspring. Matern Child Health J. 2008; 12, 394–401.
114.Morris, MS, Fava, M, Jacques, PF, Selhub, J, Rosenberg, IH. Depression and folate status in the US Population. Psychother Psychosom. 2003; 72, 80–87.
115.Young, SN. Folate and depression: a neglected problem. J Psychiatry Neurosci. 2007; 32, 80–82.
116.Coppen, A, Bolander-Gouaille, C. Treatment of depression: time to consider folic acid and vitamin B12. J Psychopharmacol. 2005; 19, 59–65.
117.Papakostas, GI, Cassiello, CF, Iovieno, N. Folates and S-adenosylmethionine for major depressive disorder. Can J Psychiatry. 2012; 57, 406–413.
118.Bottiglieri, T. Folate, vitamin B12, and neuropsychiatric disorders. Nutr Rev. 1996; 54, 382–390.
119.Farah, A. The role of L-methylfolate in depressive disorders. CNS Spectr. 2009; 14(Suppl 2), 2–7.
120.Abou-Saleh, MT, Coppen, A. Folic acid and the treatment of depression. J Psychosom Res. 2006; 61, 285–287.
121.McDonnell, R, Johnson, Z, Doyle, A, Sayers, G. Determinants of folic acid knowledge and use among antenatal women. J Public Health Med. 1999; 21, 145–149.
122.Salihu, HM, Ghaji, N, Mbah, AK, et al. Particulate pollutants and racial/ethnic disparity in feto-infant morbidity outcomes. Matern Child Health J. 2011. 16, 1679–1687.
123.Dolinoy, DC, Huang, D, Jirtle, RL. Maternal nutrient supplementation counteracts bisphenol A-induced DNA hypomethylation in early development. Proc Natl Acad Sci USA. 2007; 104, 13056–13061.
124.Singh, S, Li, SS. Epigenetic effects of environmental chemicals bisphenol a and phthalates. Int J Mol Sci. 2012; 13, 10143–10153.
125.Sullivan, FM. Impact of the environment on reproduction from conception to parturition. Environ Health Perspect. 1993; 101(Suppl 2), 13–18.
126.Sever, LE. Looking for causes of neural tube defects: where does the environment fit in? Environ Health Perspect. 1995; 103(Suppl 6), 165–171.